Insider Transactions in Q1 2024 at Boston Scientific Corp (BSX)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 18
2024
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Open market or private sale
|
Direct |
14,506
-19.98%
|
$957,396
$66.45 P/Share
|
|
Mar 01
2024
|
Wendy Carruthers EVP, Human Resources |
SELL
Open market or private sale
|
Direct |
6,983
-11.49%
|
$460,878
$66.35 P/Share
|
|
Mar 01
2024
|
Wendy Carruthers EVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
4,263
+3.41%
|
$85,260
$20.91 P/Share
|
|
Feb 26
2024
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
SELL
Open market or private sale
|
Direct |
9,335
-24.39%
|
$625,445
$67.07 P/Share
|
|
Feb 26
2024
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
BUY
Exercise of conversion of derivative security
|
Direct |
4,185
+5.21%
|
$79,515
$19.99 P/Share
|
|
Feb 23
2024
|
Wendy Carruthers EVP, Human Resources |
SELL
Open market or private sale
|
Direct |
6,983
-11.0%
|
$460,878
$66.89 P/Share
|
|
Feb 23
2024
|
Wendy Carruthers EVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
4,263
+3.27%
|
$85,260
$20.91 P/Share
|
|
Feb 21
2024
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Open market or private sale
|
Direct |
4,960
-6.39%
|
$327,360
$66.35 P/Share
|
|
Feb 20
2024
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
SELL
Discretionary transaction
|
Indirect |
67,974
-100.0%
|
$4,486,284
$66.22 P/Share
|
|
Feb 20
2024
|
Daniel J. Brennan EVP and CFO |
SELL
Open market or private sale
|
Direct |
13,662
-4.79%
|
$888,030
$65.86 P/Share
|
|
Feb 20
2024
|
Daniel J. Brennan EVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
13,662
+4.57%
|
$177,606
$13.08 P/Share
|
|
Feb 20
2024
|
Wendy Carruthers EVP, Human Resources |
SELL
Bona fide gift
|
Direct |
3,050
-4.9%
|
-
|
|
Feb 18
2024
|
Vance R Brown SVP, GC and Corp. Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
218
-0.67%
|
$14,170
$65.82 P/Share
|
|
Feb 18
2024
|
Vance R Brown SVP, GC and Corp. Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
741
+2.23%
|
-
|
|
Feb 18
2024
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
SELL
Payment of exercise price or tax liability
|
Direct |
1,829
-0.94%
|
$118,885
$65.82 P/Share
|
|
Feb 18
2024
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
BUY
Exercise of conversion of derivative security
|
Direct |
3,706
+1.87%
|
-
|
|
Feb 18
2024
|
Daniel J. Brennan EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,644
-0.6%
|
$106,860
$65.82 P/Share
|
|
Feb 18
2024
|
Daniel J. Brennan EVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,706
+1.34%
|
-
|
|
Feb 18
2024
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
SELL
Payment of exercise price or tax liability
|
Direct |
1,052
-2.99%
|
$68,380
$65.82 P/Share
|
|
Feb 18
2024
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
BUY
Exercise of conversion of derivative security
|
Direct |
2,372
+6.32%
|
-
|
|
Feb 18
2024
|
Michael F Mahoney Chairman, President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,233
-0.43%
|
$470,145
$65.82 P/Share
|
|
Feb 18
2024
|
Michael F Mahoney Chairman, President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
16,307
+0.96%
|
-
|
|
Feb 18
2024
|
Wendy Carruthers EVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
822
-1.3%
|
$53,430
$65.82 P/Share
|
|
Feb 18
2024
|
Wendy Carruthers EVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
1,853
+2.85%
|
-
|
|
Feb 18
2024
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Payment of exercise price or tax liability
|
Direct |
1,285
-1.63%
|
$83,525
$65.82 P/Share
|
|
Feb 18
2024
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
BUY
Exercise of conversion of derivative security
|
Direct |
2,817
+3.45%
|
-
|
|
Feb 18
2024
|
Jonathan Monson SVP, Global Controller and CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
258
-0.67%
|
$16,770
$65.82 P/Share
|
|
Feb 18
2024
|
Jonathan Monson SVP, Global Controller and CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
638
+1.64%
|
-
|
|
Feb 18
2024
|
John Bradley Sorenson EVP, Global Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
541
-1.06%
|
$35,165
$65.82 P/Share
|
|
Feb 18
2024
|
John Bradley Sorenson EVP, Global Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
1,186
+2.26%
|
-
|
|
Feb 18
2024
|
Eric Francis Yves Thepaut EVP & Pres, Eur, Mid-East, Afr |
SELL
Payment of exercise price or tax liability
|
Direct |
1,160
-3.72%
|
$75,400
$65.82 P/Share
|
|
Feb 18
2024
|
Eric Francis Yves Thepaut EVP & Pres, Eur, Mid-East, Afr |
BUY
Exercise of conversion of derivative security
|
Direct |
2,002
+6.03%
|
-
|
|
Feb 17
2024
|
Vance R Brown SVP, GC and Corp. Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
294
-0.92%
|
$19,110
$65.82 P/Share
|
|
Feb 17
2024
|
Vance R Brown SVP, GC and Corp. Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+3.02%
|
-
|
|
Feb 17
2024
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
SELL
Payment of exercise price or tax liability
|
Direct |
2,057
-1.07%
|
$133,705
$65.82 P/Share
|
|
Feb 17
2024
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
BUY
Exercise of conversion of derivative security
|
Direct |
4,167
+2.11%
|
-
|
|
Feb 17
2024
|
Daniel J. Brennan EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,033
-0.75%
|
$132,145
$65.82 P/Share
|
|
Feb 17
2024
|
Daniel J. Brennan EVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,583
+1.66%
|
-
|
|
Feb 17
2024
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
SELL
Payment of exercise price or tax liability
|
Direct |
1,257
-3.69%
|
$81,705
$65.82 P/Share
|
|
Feb 17
2024
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
BUY
Exercise of conversion of derivative security
|
Direct |
2,833
+7.69%
|
-
|
|
Feb 17
2024
|
Michael F Mahoney Chairman, President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
8,131
-0.49%
|
$528,515
$65.82 P/Share
|
|
Feb 17
2024
|
Michael F Mahoney Chairman, President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
18,333
+1.08%
|
-
|
|
Feb 17
2024
|
Wendy Carruthers EVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
998
-1.6%
|
$64,870
$65.82 P/Share
|
|
Feb 17
2024
|
Wendy Carruthers EVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
2,250
+3.49%
|
-
|
|
Feb 17
2024
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Payment of exercise price or tax liability
|
Direct |
1,520
-1.96%
|
$98,800
$65.82 P/Share
|
|
Feb 17
2024
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
BUY
Exercise of conversion of derivative security
|
Direct |
3,333
+4.12%
|
-
|
|
Feb 17
2024
|
Jonathan Monson SVP, Global Controller and CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
404
-1.06%
|
$26,260
$65.82 P/Share
|
|
Feb 17
2024
|
Jonathan Monson SVP, Global Controller and CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+2.56%
|
-
|
|
Feb 17
2024
|
John Bradley Sorenson EVP, Global Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
685
-1.35%
|
$44,525
$65.82 P/Share
|
|
Feb 17
2024
|
John Bradley Sorenson EVP, Global Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
1,500
+2.87%
|
-
|